Tilpisertib and its Impurities
Tilpisertib also known as GS-4875, and its prodrug Tilpisertib fosmecarbil (GS-5290) are investigational small-molecule drugs developed by Gilead Sciences for the treatment of inflammatory diseases, particularly ulcerative colitis. Reference standards of Tilpisertib API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.